We establish strategic partnership with the pharma industry to accelerate their projects and reduce the time-to-market.
We develop new technology to improve the culture of human embryos and boost their competence for implantation.
We provide strategic support with advanced cell culture technology and cell therapies, including: embryonic stem cells, iPS, hematopoietic cells or CAR-T cell technology among others.
and human embryos at Cornell Univ. and Vrije Univ.
She is inventor in international patents and holds an MBA degree.
He has been Human Frontiers of Science and Marie Curie fellow. Currently he is the group leader in the Bioengineering for Reproductive lab at IBEC.
He established his own business as an Independent Consultant in Business Strategy and became the Aerospace Technology Advisor for the Innovation and Business Development Agency – Government of Catalonia-. He was key in setting up the Aerospace Technology Technology (CTAE) in Barcelona and held the position of Deputy Director for 5 years there. Later on he set up and managed the European Space Agency Business Incubation Centre in Barcelona.
Today he works as an strategy advisor in entrepreneurship and business growth, funding high-technology businesses and being invited regularly to lecture in universities and business schools.
A multidisciplinary team bridges the gap between basic research and industry needs.
He has the know-how to guide IVFTECH in its growth in the coming years.
Delivery Executive at SAP
Professor Fraser is a former Caltech PI now works at USC.
Scott E. Fraser
Provost professor at USC